Palmitoylethanolamide (PEA, Powder)

Analytical Code: 8804

amide (amide) of fatty acids within the body It has been shown to bind to receptors in the cell nucleus. which is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation

฿81.94
gram
Min: 0g
pieces
trending_down

Unit price will be cheaper for larger size

The price will be calculated based on the size you enter

Palmitoylethanolamide (PEA) amide (amide) of fatty acids within the body. It has been shown to bind to receptors in the cell nucleus. It is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation.

PEA has been shown in clinical trials to help reduce the severity of peripheral neuropathy such as diabetic neuropathy, chemotherapy-induced peripheral neuropathy, osteoarthritis pain, low back pain, and chemotherapy. Postoperative pain, toothache, neuropathic pain in stroke and sclerosis, chronic pelvic pain.

 

It is now used as an ingredient in dietary supplements. many countries

The Food and Drug Administration (FDA) of Thailand has not yet allowed its use in dietary supplements.

this item Sold for research purposes only, not for human use.


  • Room (25-40C)
  • 24 Months from manufacturing or testing date.
    • NOT contain Egg
  • 300mg - 600mg
  • 300mg - 600mg
  • Add into oil phase. Heat tolerant.
  • Avoid heat above 70C
  • 4.00 - 5.50
  • Soluble in Oil, Soluble in Ethanol, Soluble in DMSO (Dimethyl Sulfoxide)
  • -
Test Name Specification
Appearance Fine white crystal powder
Color White to Off-white
Identification Positive
Loss on Drying 1.0% Max
Water 1.0% Max
Residue on ignition 0.1% Max
Purity (HPLC) 99.0% Min
Lead (Pb) 0.5 mg/kg Max
Total Arsenic (As) 0.15 mg/kg Max
Cadmium 2.5 mg/kg Max
Total Mercury (Hg) 1.5 mg/kg Max
Residue solvent: Methanol 0.3% Max
Residue solvent: Ethanol 0.5% Max
Residue solvent: Ethyl acetate 0.5% Max
Total Plate Count 10000CFU/g Max

Palmitoylethanolamide (PEA, Powder)

amide (amide) of fatty acids within the body It has been shown to bind to receptors in the cell nucleus. which is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation

Palmitoylethanolamide (PEA) amide (amide) of fatty acids within the body. It has been shown to bind to receptors in the cell nucleus. It is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation.

PEA has been shown in clinical trials to help reduce the severity of peripheral neuropathy such as diabetic neuropathy, chemotherapy-induced peripheral neuropathy, osteoarthritis pain, low back pain, and chemotherapy. Postoperative pain, toothache, neuropathic pain in stroke and sclerosis, chronic pelvic pain.

 

It is now used as an ingredient in dietary supplements. many countries

The Food and Drug Administration (FDA) of Thailand has not yet allowed its use in dietary supplements.

this item Sold for research purposes only, not for human use.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...